PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE

Show other versions (1)

Aim. To pursue pharmacoeconomic analysis of two drug combinations of ACE inhibitor (enalapril) and diuretic.Material and methods. Patients with arterial hypertension degree 2 and diabetes mellitus type 2 without ischemic heart disease (n=56) were included into the study. Blood pressure (BP) dynamics...

Full description

Bibliographic Details
Main Authors:	E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	combined antihypertensive therapy pharmacoeconomic analysis generics
Online Access:	https://www.rpcardio.online/jour/article/view/181

Similar Items

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

Pharmacoeconomic analysis of ischemic stroke therapy in patients with arterial hypertension
by: Mashin V.V., et al.
Published: (2010-09-01)

Prescribing patterns and pharmacoeconomic analysis of antihypertensive drugs in South Indian population: A cross-sectional study
by: S Shanmugapriya, et al.
Published: (2023-01-01)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
by: I Yu Demidova, et al.
Published: (2009-06-01)

ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING
by: N. S. Maksimchuk-Kolobova, et al.
Published: (2015-09-01)

ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING
by: N. S. Maksimchuk-Kolobova, et al.
Published: (2015-09-01)

Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
by: O. S. Mikhaylova, et al.
Published: (2022-07-01)

Outpatient antihypertensive drug utilization in Canton Sarajevo during five years period (2004-2008) and adherence to treatment guidelines assessment
by: Tarik Čatić, et al.
Published: (2011-05-01)

Full-dose combinations of antihypertensive drugs: What has changed in experts' guidelines?
by: V V Fomin, et al.
Published: (2014-10-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017-07-01)

What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)

An economic evaluation of antihypertensive therapies based on clinical trials
by: Rosana Lima Garcia Tsuji, et al.
Published: (2012-01-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
by: S. R. Gilyarevskiy, et al.
Published: (2019-05-01)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
by: Viktoriya Borisovna Mychka, et al.
Published: (2009-03-01)

ECONOMIC REASONS FOR GENERIC CHOICE
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY)
by: S. Yu. Martsevich, et al.
Published: (2020-11-01)

ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Real-world effectiveness of generic antihypertensive drugs of pradhan mantri bhartiya janaushadhi kendra
by: Chandani Sheikh, et al.
Published: (2022-01-01)

Pharmacoeconomics of Bronchial Asthma
by: Ivanova Zlatina I., et al.
Published: (2019-06-01)

THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Pharmacoeconomic analysis of classic and alternative eradication therapy regimens for Helicobacter pylori
by: A. M. Veliyev, et al.
Published: (2019-05-01)

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
by: Milewska S, et al.
Published: (2021-09-01)

THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Fixed-dose versus separate drug combinations for antihypertensive treatment: literature review
by: José Luis Calleja Rivero
Published: (2016-09-01)

Pharmacoeconomic aspects of pharmaceutical ethics
by: Huk Karina Ruslanivna, et al.
Published: (2022-01-01)

PHARMACOECONOMIC ANALYSIS OF EFFICACY OF DIFFERENT MODES OF ANTIBIOTIC PROPHYLAXIS IN CHOLECYSTECTOMY
by: A. N. Poborskiy, et al.
Published: (2016-10-01)

TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS
by: S. V. Malchikova, et al.
Published: (2016-01-01)

The results of the international clinical study VICTORY:efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide(Valsacor® H)in routine clinical practice in patients with hypertens
by: Chazova I.E., et al.
Published: (2017-05-01)

Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial
by: I E Chazova, et al.
Published: (2013-10-01)

Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
by: O. N. Gerasimova, et al.
Published: (2011-12-01)

Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital
by: L. N. Sheikhmambetova, et al.
Published: (2021-10-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)